Regulating Direct‐to‐Consumer Prescription Drug Advertising in the United States
Congress should provide FDA with equal authority over compounded drug promotion as it has for prescription drug promotion. FDA should issue regulations or guidance on modern forms of DTC advertising. The learned intermediary is based on outdated concepts and should be reconsidered by state legislatures and courts.
Authors
- Jennifer L. Pomeranz (ORCID: https://orcid.org/0009-0008-6949-763X)
- ERIKA HANSON
- DARIUSH MOZAFFARIAN
Institutions
- Tufts University (US)
- National Health Law Program (US)
- New York University (US)
Publication Details
- Journal
- Milbank Quarterly
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1111/1468-0009.70071
- Primary Topic
- Pharmaceutical industry and healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Oxford
- National Institutes of Health
- National Heart, Lung, and Blood Institute